Efficacy of patient questionnaire in predicting renal dysfunction in outpatients older than 60 years of age prior to contrast-enhanced computed tomography

Journal of Medical Imaging and Radiation Oncology

Volumn 56, Issue 2, 2012, Pages 168-172

  Lui, Elaine H ^a,b   Lau, Kenneth K ^a,c,d   Polkinghorne, Kevan ^a,c,d   Chang, Chian A ^a,c   Ardley, Nicholas ^a,c  

^a MONASH MEDICAL CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Southern Healthcare Network   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Computed tomography; Contrast; Questionnaire; Renal

Indexed keywords

CREATININE; PROTEIN;

ADULT; AGE; AGED; ANEMIA; ARTICLE; CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FALSE NEGATIVE RESULT; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; GOUT; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYELOMA; OUTCOME ASSESSMENT; OUTPATIENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VASCULITIS;

AGED; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; OUTPATIENTS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84859789467     PISSN: 17549477     EISSN: 17549485     Source Type: Journal    
DOI: 10.1111/j.1754-9485.2011.02323.x     Document Type: Article

References (13)

1. Thomson HS, Morcos SK. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 2003; 76: 513-18. (Pubitemid 37028403)
2. McCullough PA, Adam A, Becker CR et al. Epidemiology and prognostic implications of contrast induced nephropathy. Am J Cardiol 2006; 98 (Suppl): 5K-13K.
3. Mautone A, Brown JR. Contrast induced nephropathy in patients undergoing elective and urgent procedures. J Interv Cardiol 2010; 23: 78-85.
4. Alwall N, Erlanson P, Tornberg A. This clinical course of renal failure occurring after intravenous urography and/or retrograde pyelography; casuistics of 11 cases (including 7 deaths); on indications for and risks involved in the use of contrast media, including some remarks on the risk of aspiration biopsy of the kidney. Acta Med Scand 1955; 152: 163-73.
5. Bettman MA. Contrast medium induced nephropathy: critical review of the existing clinical evidence. Nephrol Dial Transplant 2005; 20 (Suppl 1): i12-17.
6. Cronin RE. Contrast induced nephropathy: pathogenesis and prevention. Pediatr Nephrol 2010; 25: 191-204.
7. Mitchell AM, Jones AE, Tumlin JA, Kline JA. Incidence of contrast induced nephropathy after contrast enhanced computed tomography in the outpatient setting. Clin J Am Soc Nephrol 2010; 5: 4-9.
8. McCullough PA, Stacul F, Becker CR. Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary. Rev Cardiovasc Med 2006; 7: 177-97. (Pubitemid 46139115)
9. Thomsen HS, Morcos SK. In which patients should serum creatinine be measured before iodinated contrast medium administration? Eur Radiol 2005; 15: 749-54.
10. Royal Australian and New Zealand College of Radiologists. RANZCR Guidelines for Iodinated Contrast Administration - 2009 Edition [cited 2 Jan 20] http://www.ranzcr.edu.au/quality-a-safety/resources
11. Kidney Health Australia. GFR calculator 2008. 2008. [Cited 2 Jan 2012.] Available from URL: http://www.kidney.org.au/HealthProfessionals/tabid/582/ Default.aspx
12. Tippins RB, Torres WE, Baumgartner BR, Baumgarten DA. Are screening serum creatinine levels necessary prior to outpatient CT examinations? Radiology 2000; 216: 481-4. (Pubitemid 30599870)
13. Choyke PL. Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients? Tech Urol 1998; 4 (2): 65-9. (Pubitemid 28237617)